Insufficient scRNA-seq data for expression of ENDOU at single-cell level.
Insufficient scRNA-seq data for expression of ENDOU at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 66% | 191.43 | 1731 / 2642 | 81% | 3.04 | 571 / 705 |
ovary | 78% | 185.15 | 140 / 180 | 33% | 1.26 | 144 / 430 |
esophagus | 54% | 2922.51 | 774 / 1445 | 37% | 5.86 | 68 / 183 |
skin | 76% | 1456.02 | 1376 / 1809 | 14% | 0.74 | 67 / 472 |
breast | 58% | 124.24 | 264 / 459 | 11% | 0.31 | 120 / 1118 |
thymus | 33% | 63.64 | 215 / 653 | 22% | 0.44 | 131 / 605 |
adipose | 53% | 168.57 | 643 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 47% | 3.30 | 21 / 45 |
bladder | 29% | 48.00 | 6 / 21 | 8% | 0.60 | 38 / 504 |
uterus | 11% | 86.98 | 19 / 170 | 23% | 2.05 | 104 / 459 |
lung | 20% | 45.74 | 114 / 578 | 10% | 0.35 | 111 / 1155 |
kidney | 24% | 72.70 | 21 / 89 | 2% | 0.03 | 17 / 901 |
blood vessel | 24% | 62.37 | 314 / 1335 | 0% | 0 | 0 / 0 |
intestine | 12% | 25.08 | 119 / 966 | 4% | 0.67 | 21 / 527 |
stomach | 13% | 26.89 | 46 / 359 | 1% | 0.02 | 3 / 286 |
adrenal gland | 0% | 0 | 0 / 258 | 10% | 0.32 | 24 / 230 |
lymph node | 0% | 0 | 0 / 0 | 10% | 0.14 | 3 / 29 |
pancreas | 0% | 0.99 | 1 / 328 | 8% | 0.13 | 15 / 178 |
prostate | 6% | 11.90 | 15 / 245 | 2% | 0.03 | 10 / 502 |
muscle | 6% | 13.56 | 47 / 803 | 0% | 0 | 0 / 0 |
heart | 4% | 6.80 | 34 / 861 | 0% | 0 | 0 / 0 |
spleen | 4% | 8.86 | 9 / 241 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 0% | 0.00 | 1 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
GO_0016441 | Biological process | post-transcriptional gene silencing |
GO_0007565 | Biological process | female pregnancy |
GO_0006955 | Biological process | immune response |
GO_0016192 | Biological process | vesicle-mediated transport |
GO_0006508 | Biological process | proteolysis |
GO_0050995 | Biological process | negative regulation of lipid catabolic process |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0004521 | Molecular function | RNA endonuclease activity |
GO_0030247 | Molecular function | polysaccharide binding |
GO_0008083 | Molecular function | growth factor activity |
GO_0005044 | Molecular function | scavenger receptor activity |
GO_0030145 | Molecular function | manganese ion binding |
GO_0008236 | Molecular function | serine-type peptidase activity |
GO_0003723 | Molecular function | RNA binding |
GO_0016829 | Molecular function | lyase activity |
Gene name | ENDOU |
Protein name | Uridylate-specific endoribonuclease (EC 4.6.1.-) (Placental protein 11) (PP11) (Protein endoU) |
Synonyms | |
Description | FUNCTION: Endoribonuclease that cleaves single-stranded RNAs at 5' of uridylates and releases a product with a 2',3'-cyclic phosphate at the 3'-end. The UU and GU sites are more efficiently cleaved than CU and AU sites. . |
Accessions | P21128 ENST00000422538.8 [P21128-1] ENST00000545824.2 [P21128-3] ENST00000229003.7 [P21128-2] |